Amanda Braga de Figueiredo

CV Lattes ResearcherID ORCID Google Scholar Citations

Fundação Antonio Prudente (FAP). A C Camargo Cancer Center (Institutional affiliation from the last research proposal)
Birthplace: Brazil

graduation at Nutrição from Universidade Federal de Ouro Preto (2009), master's at General Biology from Universidade Federal de Ouro Preto (2012) and doctorate at General Biology from Universidade Federal de Ouro Preto (2016). Has experience in Immunology, focusing on Immunology (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Completed (most recent)

Abstract
The overall rate in patients treated with anti-PD1 therapy is up to 45% as first line therapy in patients with non-small cell lung cancer (NSCLC). In patients with malignant melanoma, the efficacy is around 30%. The elucidation of the factors responsible for treatment failure is fundamental for the development of new therapeutic approaches. Two factors are essential for influencing the pa…
A prospective study to elucidate systemic and tumor microenvironment immunoregulatory networks related to anti-PD1 treatment failure in stage IV NSCLC and melanoma patients, BP.PD

Virtual Library in numbers * Updated data on August 16, 2025

Total / Available in English

1 / 1	Completed scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Kenneth John Gollob

Keywords used by the researcher

Biological Sciences Immunology

Please report errors on the page using this form.

Short URL

Abstract